Health Canada drug identification number

DIN 02230592 — NEOSTIGMINE OMEGA 1 MG

NEOSTIGMINE OMEGA is a liquid of Neostigmine Methylsulfate marketed by OMEGA LABORATORIES LIMITED. The full Neostigmine Methylsulfate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02230592
Brand name
NEOSTIGMINE OMEGA
Active ingredient
Neostigmine Methylsulfate
Strength
1 MG
Dosage form
LIQUID
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Manufacturer
OMEGA LABORATORIES LIMITED
Health Canada status
MARKETED
Drug class
Cholinesterase inhibitor (parasympathomimetic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Neostigmine Methylsulfate products

DINBrandStrengthFormManufacturerStatus
02475480 NEOSTIGMINE METHYLSULFATE INJECTION USP 0.5 MG SOLUTION MARCAN PHARMACEUTICALS INC MARKETED
02475499 NEOSTIGMINE METHYLSULFATE INJECTION USP 1 MG SOLUTION MARCAN PHARMACEUTICALS INC MARKETED
02537516 NEOSTIGMINE METHYLSULFATE INJECTION, USP 0.5 MG SOLUTION JAMP PHARMA CORPORATION MARKETED
02230593 NEOSTIGMINE OMEGA 0.5 MG LIQUID OMEGA LABORATORIES LIMITED MARKETED
02387166 NEOSTIGMINE OMEGA 2.5 MG SOLUTION OMEGA LABORATORIES LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.